Malignant neoplasm of parathyroid gland
ICD-10 C75.0 is a billable code used to indicate a diagnosis of malignant neoplasm of parathyroid gland.
Malignant neoplasm of the parathyroid gland is a rare endocrine tumor that arises from the parathyroid tissue, which is responsible for regulating calcium levels in the body through the secretion of parathyroid hormone (PTH). This neoplasm can lead to hyperparathyroidism, characterized by elevated calcium levels, which may result in various metabolic disturbances such as bone pain, kidney stones, and neuromuscular symptoms. The malignancy can present with local symptoms such as neck swelling or pain, and may metastasize to regional lymph nodes or distant organs. Diagnosis typically involves imaging studies, serum calcium and PTH levels, and histopathological examination following biopsy. Treatment often requires surgical intervention, and in some cases, adjunctive therapies may be necessary. Due to its rarity, awareness and accurate coding of this condition are crucial for proper management and reimbursement.
Comprehensive documentation of hormone levels, imaging studies, and biopsy results.
Patients presenting with hypercalcemia, neck masses, or unexplained bone pain.
Ensure clear documentation of the malignancy's nature and any associated metabolic disorders.
Detailed operative reports, pathology findings, and follow-up care notes.
Surgical intervention for parathyroid tumors, including pre-operative imaging and post-operative outcomes.
Accurate staging and documentation of surgical margins are critical for coding.
Performed for malignant parathyroid tumors.
Operative report detailing the procedure and findings.
Endocrinologists and surgeons must collaborate on documentation.
Common symptoms include hypercalcemia, bone pain, kidney stones, and neuromuscular symptoms such as weakness and fatigue.
